Mach7 Technologies Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume272,627 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive M7T News and Ratings via Email

Sign-up to receive the latest news and ratings for Mach7 Technologies and its competitors with MarketBeat's FREE daily newsletter.

About Mach7 Technologies

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. The company operates through two segments, Sale of Software Licenses and Provision of Professional Services. It offers Management Studio that enables healthcare delivery organizations to own, archive, and communicate imaging data across the enterprise and connect that data with the electronic medical record. The company's Management Studio comprises enterprise imaging platform, vendor neutral archive, communication workflow engine, routing engine, fetching engine, and migration engine products. It also provides Diagnostic Studio that includes a suite of solutions to drive specialty workflows. The company's Diagnostic Studio solutions include PACS and QC solution; and Universal Worklist. In addition, the company offers Clinical Studio, which provides access to view, navigate, review, and share patient medical data over the Web and across the enterprise. Its Clinical Studio solutions consist of clinical portal, clinical viewer, image sharing, and procedure import/export products, as well as iModality, a mobile medical image capture using smart device technology. Further, the company provides professional services, such as implementation and training, data migration, support, and maintenance services; and archive migration services. Mach7 Technologies Limited was founded in 2007 and is based in South Burlington, Vermont.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.32 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Mach7 Technologies (ASX:M7T) Frequently Asked Questions

What stocks does MarketBeat like better than Mach7 Technologies?

Wall Street analysts have given Mach7 Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mach7 Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Mach7 Technologies' key executives?

Mach7 Technologies' management team includes the following people:
  • Mr. Michael Lampron, CEO, MD & Director
  • Ms. Jennifer Lee Pilcher C.A., CA, BBS, AGIA, Global CFO & Corp. Sec.
  • Mr. Bob Tranchida, VP of Marketing
  • Mr. David Madaffri, Sr. VP of Global Sales
  • Ms. Sue Stasny, Head of People & Culture
  • Mr. Steve Rankin, Chief Product Officer

Who are some of Mach7 Technologies' key competitors?

What other stocks do shareholders of Mach7 Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mach7 Technologies investors own include MicroVision (MVIS), Genex Power (GNX), Corning (GLW) and Denali Therapeutics (DNLI).

What is Mach7 Technologies' stock symbol?

Mach7 Technologies trades on the ASX under the ticker symbol "M7T."

How much money does Mach7 Technologies make?

Mach7 Technologies has a market capitalization of $0.00 and generates $16.89 million in revenue each year.

What is Mach7 Technologies' official website?

The official website for Mach7 Technologies is

How can I contact Mach7 Technologies?

The company can be reached via phone at 802-861-7745.

This page was last updated on 8/4/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.